---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-025654"
form_type: "8-K/A"
ticker: "FLNA"
cik: "0001069530"
company_name: "FILANA THERAPEUTICS, INC."
filed_at: "2024-08-09T23:59:59+00:00"
generated_at: "2026-05-31T10:19:35.341533+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Cassava Sciences corrects diluted EPS for H1 2024 to ($0.28) from ($1.72)

## Summary
- Corrected diluted EPS for six months ended June 30, 2024 is $(0.28), not $(1.72) as originally reported.
- No other financial figures in the August 8, 2024 earnings release are affected by this amendment.
- Corrected figure matches diluted EPS reported in the Form 10-Q filed on August 8, 2024.
- Amendment filed on August 9, 2024; initial 8-K remains unchanged except for the EPS correction.

## SEC filing metadata
- accession: 0001437749-24-025654
- form_type: 8-K/A
- ticker: FLNA
- cik: 0001069530
- company_name: FILANA THERAPEUTICS, INC.
- filed_at: 2024-08-09T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069530/000143774924025654/0001437749-24-025654-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069530/000143774924025654/sava20240809_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-025654
- JSON: https://secwatch.observer/filing/0001437749-24-025654.json
- Plain text: https://secwatch.observer/filing/0001437749-24-025654.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.